MedPath

Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine

Phase 4
Completed
Conditions
Spinal Anesthesia
Interventions
Registration Number
NCT01245868
Lead Sponsor
Frederikssunds Hospital, Denmark
Brief Summary

The purpose of the study is to investigate if a small amount of lignocaine added to bupivacaine for spinal anesthesia to patients planned for arthroscopic knee surgery, can shorten the duration of the sensoric and the motoric blockade.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The patient want spinal anaesthesia
  • No contradictions against spinal anaesthesia
  • Healthy people (ASA-score 1 or 2)
  • Body mass index < 35 and between 155 and 190 cm
Read More
Exclusion Criteria
  • Known allergic reactions to planned drugs
  • Neurologic disturbances
  • Diabetes
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lidocaine added to bupivacainebupivacainelidocaine is added to bupivacaine
BupivacainebupivacaineBupivacaine as used routinely
Lidocaine added to bupivacaineLidocainelidocaine is added to bupivacaine
Primary Outcome Measures
NameTimeMethod
Duration of spinal blockadeRepeating monitoring every 15 minutes after applying the blockade, up to 360 minutes.
Secondary Outcome Measures
NameTimeMethod
Time to fulfillment of discharge criteria from the hospital.Evaluated every 15 minutes after the operation up to 360 minutes. On average 200 to 300 minutes.

Trial Locations

Locations (2)

Dep. of anesthesiology, Hospital of Frederikssund

🇩🇰

Frederikssund, Denmark

Jon Jacobsen

🇩🇰

Frederikssund, Denmark

© Copyright 2025. All Rights Reserved by MedPath